Tivozanib: current status and future directions in the treatment of solid tumors
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.733695
Reference37 articles.
1. Tumor Angiogenesis: Therapeutic Implications
2. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
3. The role of vascular endothelial growth factor in pathological angiogenesis
4. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for Tivozanib;2024-04-09
2. An efficient biocatalytic oxidative dehydroaromatization approach for the construction of quinolines enabled by monoamine oxidase with molecular oxygen;Green Chemistry;2023
3. Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy;Molecular and Cellular Biochemistry;2021-07-29
4. Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy;European Journal of Medicinal Chemistry;2018-01
5. Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence;Drugs & Aging;2017-02-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3